Related Experiment Video

Updated: Jun 24, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Promising novel immunotherapies and combinations for prostate cancer

Philip M Arlen1, Mahsa Mohebtash, Ravi A Madan

  • 1Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Future Oncology (London, England)
|March 17, 2009
PubMed

Insights

Therapeutic cancer vaccines show promise for prostate cancer treatment. Combination therapies and novel vaccine strategies are being investigated for future clinical use.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Therapeutic cancer vaccines are under active preclinical and clinical investigation.
  • Novel tumor immunotherapy approaches are emerging in prostate cancer research.
  • No therapeutic cancer vaccine is currently FDA-approved, but combination therapies show potential.

Purpose of the Study:

  • To review promising new vaccines for prostate cancer.
  • To discuss novel perspectives in prostate cancer treatment using immunotherapy.
  • To highlight the potential of therapeutic cancer vaccines in managing malignancies.

Main Methods:

  • Review of current preclinical and clinical investigations.
  • Analysis of recent findings in prostate cancer immunotherapy.
  • Focus on novel vaccine strategies and combination therapies.

Main Results:

  • Prostate cancer is a suitable candidate for immunotherapy due to its indolence and specific antigens.
  • Combination therapies involving vaccines may lead to broader பயன்பாடு in treating various cancers.
  • Ongoing clinical trials are exploring the efficacy of novel vaccine designs.

Conclusions:

  • Therapeutic cancer vaccines hold significant future potential for prostate cancer treatment.
  • Combination strategies are key to advancing cancer vaccine therapies.
  • Further research and well-designed clinical trials are essential for therapeutic cancer vaccine approval and application.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...